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Abstract According to epidemiological data, Can-
dida tropicalis has been related to urinary tract
infections and haematological malignancy. Several
virulence factors seem to be responsible for C.
tropicalis infections, for example: their ability to
adhere and to form biofilms onto different indwelling
medical devices; their capacity to adhere, invade and
damage host human tissues due to enzymes production
such as proteinases. The main aim of this work was to
study the behaviour of C. tropicalis biofilms of
different ages (24–120 h) formed in artificial urine
(AU) and their ability to express aspartyl proteinase
(SAPT) genes. The reference strain C. tropicalis
ATCC 750 and two C. tropicalis isolates from urine
were used. Biofilms were evaluated in terms of
culturable cells by colony-forming units enumeration;
total biofilm biomass was evaluated using the crystal
violet staining method; metabolic activity was
evaluated by XTT assay; and SAPT gene expression
was determined by real-time PCR. All strains of C.
tropicalis were able to form biofilms in AU, although
with differences between strains. Candida tropicalis
biofilms showed a decrease in terms of the number of
culturable cells from 48 to 72 h. Generally, SAPT3
was highly expressed. C. tropicalis strains assayed
were able to form biofilms in the presence of AU
although in a strain- and time-dependent way, and
SAPT genes are expressed during C. tropicalis biofilm
formation.
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Introduction
Candida tropicalis ranks between the second and third
non-Candida albicans Candida species (NCAC) most
frequently isolated from patients with Candida infec-
tions [1–5]. According to epidemiological data, C.
tropicalis has been related to urinary tract infections
and haematological malignancy [3, 4, 6, 7]. Further-
more, the most important causes of C. tropicalis
candiduria are associated with antibiotic therapy and
indwelling catheterization [8–10]. Several virulence
factors seem to be responsible for C. tropicalis
infections, for example: their ability to adhere and to
form biofilms onto different indwelling medical
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devices; their capacity to adhere, invade and damage
host human tissues due to enzymes production such as
proteinases [9, 11–16]. Formation of C. tropicalis
biofilms has important clinical repercussions because
of their increased resistance to antifungal therapy and
the ability of cells within biofilms to withstand host
immune defences [17, 18]. This is important because,
according to epidemiological data, C. tropicalis
infection is strongly connected with the presence of
biofilms in urinary catheters [12, 19–23]. In the last
decade, early events associated with C. tropicalis
biofilm formation have received considerable atten-
tion [11, 12, 14, 16, 24]. However, very little is known
about the behaviour and presence of enzymes, such as
proteinases, in C. tropicalis biofilm formation. Fur-
thermore, recent studies with C. albicans demon-
strated that biofilm cells display a distinct phenotype,
which is associated with an increased virulence, such
as the ability to produce hydrolytic enzymes [25].
Thus, the aim of this study was to investigate the
behaviour of C. tropicalis biofilms formed in the
presence of artificial urine and their ability to express
aspartyl proteinase (SAPT) genes.
Materials and Methods
Candida tropicalis and Growth Conditions
Three strains of C. tropicalis were used in this study:
one reference strain from the American Type Culture
Collection (ATCC 750) and two clinical isolates (U69
and U75) obtained from patients with candiduria
admitted to the intensive care unit and belonging to the
archive collection of the University Hospital in
Maringa´, Parana´, Brazil. The yeasts were identified
by three methods: the MicroScan rapid yeast identi-
fication panel (Dade Behring Inc, CA, USA), the
classical biochemical method and molecular identifi-
cation [15]. The strains were kept frozen at -80 C in
Sabouraud dextrose broth (SDB; Liofilchem, Italy)
containing 5 % (v v-1) glycerol. For each experiment,
strains were subcultured on Sabouraud dextrose agar
(SDA; Merck, Darmstadt, Germany) for 48 h at
37 C. Yeast cells were then inoculated in Sabouraud
dextrose broth (SDB;Merck) and incubated for 18 h at
37 C under agitation in an orbital shaker (120 rev/
min). After incubation, yeast cells were harvested by
centrifugation at 80009g for 5 min at 4 C and
washed twice with phosphate buffer solution (PBS;
pH 7.5; 0.01 mol l-1). The remaining pellets were
suspended in artificial urine (AU), and the cellular
density adjusted to 1 9 107 yeasts mL-1, using a
Neubauer chamber. Artificial urine (pH 5.8) was
prepared according to Silva et al. [11].
Candida tropicalis Biofilms Formation
Biofilms, with different ages of maturation (24, 48, 72,
96 and 120 h), were formed on silicone coupons
(1 9 1 cm-2) according to Silva et al. [11]. The
coupons were placed in 24-well microtiter plates
(Orange Scientific, Braine-l0Alleud, Belgium), and
1 mL of standardized C. tropicalis suspension
(1 9 107 yeasts mL-1 in AU) was added to each
well. The microtiter plates were incubated for
24–120 h at 37 C in an orbital shaker (120 rev/
min). Every 24 h, an aliquot of 500 lL of AU was
removed and an equal volume of fresh AU added to
each well. The silicone coupons used as controls were
similarly treated but in the absence of C. tropicalis.
After the defined times of incubation, the medium was
aspirated and non-adherent C. tropicalis cells were
removed by washing the silicone coupons with PBS.
Candida tropicalis Biofilm Characterization
Biofilms, recovered at each time point, were evaluated
in terms of: (1) number of culturable yeasts by colony-
forming units (CFU) enumeration; (2) total biofilm
biomass using the crystal violet (CV) staining method;
(3) metabolic activity by 2,3-bis(2-methoxy-4-nitro-5-
sulfophenyl)-2H-tetrazolium-5-carboxanilide (XTT)
reduction assay. The results of CV and XTT assays
were classified according to the cut-offs proposed by
Marcos-Zambrano et al. [26]. The cut-offs used were
as follows: low (\0.44), moderate (0.44–1.17) and
high ([1.17) biofilm forming; and low (\0.097),
moderate (0.097–0.2) and high ([0.2) metabolic
activity. All experiments were repeated on three
occasions with individual samples evaluated in
triplicate.
Number of Culturable Yeasts
The number of culturable yeasts was determined by
CFU enumeration, according to Silva et al. [14] with
some modifications. Briefly, 1 mL of PBS was added
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to the silicone coupons (containing the washed
biofilms), and the biofilms were removed with a cell
scraper (Orange Scientific, Belgium). The coupons,
immersed in PBS, were sonicated (Ultrasonic Proces-
sor; Cole-Parmer) for 45 s at 30 W (parameters
optimized to avoid cell lysis). The suspensions
obtained were vortexed vigorously for 5 min, and
then serial decimal dilutions (in PBS) were plated onto
SDA. Agar plates were incubated for 24 h at 37 C,
followed by CFU enumeration, and the results were
recorded as CFU per unit area of coupon (CFU cm-2).
Biofilm Biomass Quantification by Crystal Violet
Staining
CV staining was used to assess total biomass quan-
tification (yeast, pseudohyphae, hyphae and matrix
components). Thus, at the defined time points of
incubation, the biofilms were stained in accordance
with Silva et al. [14]. The final absorbance values were
standardized according to the area of silicone coupons
(absorbance cm-2).
In Situ Biofilm Metabolic Activity
After biofilm formation (as described previously), the
reduction assay of the tetrazolium salt 2,3-bis(2-
methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide (XTT; Sigma-Aldrich, USA) [14] was
used to determine the in situ biofilm mitochondrial
activity of C. tropicalis cells in the biofilms. The
absorbance values were standardized per unit area of
well (absorbance cm-2).
Analysis of SAP Gene Expression
SAP gene expression was evaluated for planktonic and
biofilm cells. For planktonic cells, a suspension of C.
tropicalis, adjusted to 1 9 107 yeasts mL-1 in AU,
was incubated for 24 h at 37 C under agitation in an
orbital shaker (120 rev/min). Finally, the yeast cells
were harvested by centrifugation at 80009g for 5 min
at 4 C, and the pelletized cells were suspended in
500 lL of lysis buffer (Invitrogen, USA). After
biofilm formation on silicone, as described above,
the biofilms were scraped from the coupons into
500 lL of lysis buffer.
RNA Extraction
Candida tropicalis samples were transferred to screw-
cap tubes (Bioplastics, NL), and glass beads (0.5 mm
diameter, approximately 500 lL) were added before
the tubes were homogenized twice for 30 s, using a
Mini-BeadBeater-8 (Stratech Scientific, Soham, UK).
After yeast cells disruption, the PureLinkTM RNA
Mini Kit (Invitrogen) was used for total RNA extrac-
tion according to the manufacturer’s recommended
protocol. To avoid potential DNA contamination, the
samples were treated with RNase-free DNase I
(Invitrogen).
Primers
The primers used for real-time PCR (RT-PCR) were
described in Silva et al. [27] and Negri et al. [7]. The
pairs of primers were as follows: 50-GGAAGATCT
GATGTGCCAACTACATTGA-30 and 50CGTGCGG
CCGCTCTACAAAGCCGAGATGTCT-30 for SAP1,
50-TTCTTCTAGTGGTACCTGGGTCAAAG-30 and
50-CATAGATCTCTAAACAATAGTGACATTAG
A-30 for SAP2, 50-ACTTGGATTTCCAGCGAAGA-
30 and 50-AGCCCTTCCAATGCCTAAAT-30 for
SAP3, 50-GTACTCGAGCTCCTACAACTTCACC
TCCT-30 and 50-CATGGATCCCTATGTAAGTG
GAAGTATGTT-30 for SAP4, 50-GACCGAAGCTC
CAATGAATC-30 and 50-AATTGGGACAACGT
GGGTAA-30 for ACT1. The efficiency of primers
SAPT1-4 and actin 1 (ACT1) as a reference house-
keeping gene in concentration of 2 lM was evaluated
using melting curve, percentage of efficiency and
dilution with best standard curve generated by
StepOneTM software version 2.3 in titration experi-
ments using complementary DNA (cDNA) of C.
tropicalisATCC 750 both planktonic and biofilm cells
in serial log10 dilutions.
Synthesis of cDNA
To synthesize the cDNA, the iScriptTM cDNA Syn-
thesis Kit (Bio-Rad, USA) was used according to the
manufacturer’s instructions. For each sample, 10 lL
of extracted RNA was used.
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Real-Time PCR
Real-time PCR (CF X96TM Real-Time PCR System,
Bio-Rad, USA) was used to determine the relative
levels of SAPT1-4 mRNA transcripts with (ACT1) as
a reference housekeeping gene according to Silva
et al. [27] and Negri et al. [7]. Each reaction mixture
consisted of: working concentration of SsoFastTM
EvaGreen Supermix (Bio-Rad, USA), 300 nmol
forward and reverse primer and 1 lL of cDNA, in a
final reaction volume of 20 lL. Negative controls
(water) were included in each run. The relative
quantification of SAPT1-4 gene expression was
performed by the DCT method [7, 27]. Each reaction
was performed in triplicate, and mean values of
relative expression were analysed for each SAP
gene.
Statistical Analysis
The results obtained were analysed using the SPSS 18
(Statistical Package for the Social Sciences) program.
One-way ANOVA with the Bonferroni test was used
in these tests. All tests were performed with a
confidence level of 95 %. All the experiments were
performed in triplicate and in three independent
assays.
Results
Candida tropicalis Biofilm Characterization
Figure 1 presents the evaluation of biofilm formation
by the different C. tropicalis strains along time. It can
be verified that all strains were able to form biofilms in
silicone and in the presence of artificial urine (AU)
according to the results of number of cultivable yeasts,
total biomass and in situ mitochondrial biofilm
metabolic activity. The number of culturable yeasts
(Fig. 1a) from U75 and ATCC 750 biofilms was
similar in all time points assayed. However, the
clinical isolate U69 showed significantly less
(p = 0.01) culturable yeasts (1.60 9 105 CFU cm-2)
from 24-h-old biofilms and higher number of cultur-
able yeasts (1.08 9 107 CFU cm-2) from 48-h bio-
films, than the other two strains. In general, C.
tropicalis biofilms showed a decrease in terms of the
number of culturable cells from 48 to 72 h, for strains
U69 and U75, p\ 0.05. Concerning C. tropicalis
biofilm biomass, it is possible to observe (Fig. 1b) that
there were some differences between the strains and
between biofilms of different ages. The isolate U69
presented the highest biofilm biomass (p = 0.01) at
24 h (0.54 abs/cm-2) and 48 h (0.57 abs/cm-2) cor-
responding to a moderate biofilm, but for 72-h
biofilms, the highest biomass (p = 0.01) was attained
by strain U75 (1.28 abs/cm-2; high biofilm biomass),
highlighting the differences in the behaviour of the
three strains. The analysis of in situ biofilm (Fig. 1c)
indicated that all strains independently of time points
showed high metabolic activity (above 0.2 abs/cm-2).
Although there were some differences in the first time
points, there was a pattern of activity among the
different strains after 72 h; namely, there was a
significant increase (p\ 0.05) from 72 to 96 h and a
Fig. 1 Candida tropicalis biofilm characterization; a number
of culturable yeasts determined by colony-forming units;
b biofilm biomass quantification by crystal violet; c in situ
mitochondrial biofilm metabolic activity by XTT. *Statistical
difference between strains (p\ 0.05); Statistical differences
between biofilms with different ages (p\ 0.05)
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decrease from 96 to 120 h. Until 72 h, the different
strains presented distinct behaviours, while C. tropi-
calis reference strain and U69 presented a decrease in
activity from 24 h (1.15 abs/cm-2) until 72 h
(0.36 abs/cm-2) and strain U75 presented a slight
increase from 24 h (1.10 abs/cm-2) to 48 h (1.27 abs/
cm-2) and a decrease from 48 to 72 h (0.68 abs/
cm-2).
Candida tropicalis SAP Gene Expression
The primers SAPT1-4 and ACT1 demonstrated effi-
ciency and similarity in titration experiments using
cDNA of C. tropicalis ATCC 750 both planktonic and
biofilm cells (23.6–88.3 ng) in serial log10 dilutions
(data not shown). Analysing C. tropicalis SAP gene
expression (Table 1), it can be noticed that C.
tropicalis suspended cells grown in AU were not able
to express SAPT1 gene. However, cells of 48-h
biofilms of strains U69 and ATCC 750, when grown
in the sessile form, were able to express that gene with
0.02 and 0.01 of relative SAPT1 gene expression,
respectively. As regards SAPT2 gene, it was expressed
by C. tropicalis planktonic and biofilm cells, although
at low levels. In opposition to the other SAPT genes,
SAPT3was expressed in all conditions (planktonic and
biofilm), except by ATCC 750 120-h biofilm cells
(\0.01). Interestingly, the amount of this SAP gene
expressed by planktonic cells is much higher than the
amount expressed by biofilm cells. Interestingly,
SAPT4 was only expressed by the reference strain
and in few situations (48-h biofilms with 0.02 relative
SAPT4 gene expression).
Discussion
Candida tropicalis is emerging as a cause of infection
in hospitalized patients [3, 4, 8, 15, 18] being involved
in nosocomial candidemia and candiduria [9, 18].
Urinary catheter use is the principal determining factor
for the emergence of urinary yeast infections [28].
However, the information on the behaviour of Can-
dida species under human body conditions such as
urine is still limited [12, 21]. In the present study, C.
tropicalis biofilm formation in AU was investigated.
In accordance with other studies [7, 11, 14, 21], the
strains of C. tropicalis assayed here were able to form
biofilms in the presence of AU (Fig. 1), although in a
strain- and time-dependent way. Similarly, a study by
Jain et al. [21] with C. albicans, C. glabrata and C.
tropicalis, using AU and RPMI 1640, showed that
biofilm formation varied considerably among isolates
under both growth conditions.
The most common methods for analysing Candida
biofilm development include quantification of biomass
production using crystal violet (CV) stain, quantifica-
tion of the metabolic activity of viable embedded
biofilm cells based on reduction in tetrazolium salt
XTT to formazan dye and the counting of viable cells
(in terms of CFUs). These methods (CV, XTT and
CFUs) serve as complementary procedures for the
study of Candida biofilm, showing different
Table 1 Detection by quantitative RT-PCR of secreted aspartyl proteinases (SAPT1-4) gene expression by planktonic and biofilm
cells of Candida tropicalis
Strain (n) Form Range of relative expression of SAPT genes*
SAPT1 SAPT2 SAPT3 SAPT4
C. tropicalis (3) Planktonic \0.01 \0.01–0.01 9.74–25.31 \0.01
Biofilm 24 h \0.01 \0.01–0.03 0.06–2.35 \0.01
Biofilm 48 h \0.01–0.02 \0.01–0.07 0.30–20.95 \0.01–0.02
Biofilm 72 h \0.01 \0.01–0.01 0.01–1.09 \0.01
Biofilm 96 h \0.01 0.01–0.01 1.53–2.89 \0.01
Biofilm 120 h \0.01 \0.01 \0.01–1.15 \0.01
\0.01 indicates that gene expression was detected lower than 0.01
* Mean arbitrary messenger RNA transcript levels based upon triplicate measurements, presented as a percentage relative to the
respective ACT1 transcript level
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information such as quantity of metabolic activity and
total biomass compared to, for example, the counting
of viable cells results [26, 29–32]. Observing the
biofilm profile along time (Fig. 1), no consistent
pattern can be noticed among the different strains.
The only similarity among strains is an increase in the
number of culturable cells and biofilm metabolic
activity from 72- to 96-h biofilms. Variations among
C. tropicalis strains concerning biofilm formation are
expected due to the physiological differences between
strains [24, 26]. Furthermore, as reported before, C.
tropicalis species mature biofilms consist of a dense
and heterogeneous network of yeast, pseudohyphae
and hyphae and these forms are not always similar
among C. tropicalis strains. Moreover, other studies
reported that biofilm kinetics is strain dependent,
mainly in C. tropicalis strains [11, 26, 28, 33].
For instance, in the present situation, U69 strain
24-h biofilm presented the lowest number of culturable
yeasts (1.60 9 105 CFU cm-2; p = 0.01), although
showing the highest biofilm biomass (0.54 abs cm-2;
p = 0.01), considerate moderate biofilm forming [26].
However, in a previous work [12], using RPMI 1640 as
growth medium, U69 biofilm biomass was similar to
the other C. tropicalis strains, which highlights that
biofilms are dependent on growth medium, carbohy-
drate supplementation and the nature of the colonized
surface [11, 21, 24, 28].
It has been reported that culturable yeast cells and
biofilm metabolic activity seem to be dependent on
biofilm maturity with an increase in those parameters
along biofilm development although the amount of
retained product may vary between different cellular
states, for example planktonic and biofilm [11, 26, 28,
34]. From the present results, it is not possible to
establish a relation between those two parameters,
which showed variations in biofilm metabolic activity
along time; however, culturable yeast cells were
constant (except to U69 isolate).
Furthermore, C. tropicalis biofilms show opposite
kinetics (Fig. 1b, c) mainly at 24- and 72-h-old
biofilms that at the moment of reaching the peaks of
biomass production, the metabolic activity of the
biofilms is lower and the inverse effect is also shown,
corroborating with Marcos-Zambrano et al. [26].
Candida tropicalis biofilms have a thick extracellular
matrix that can impair diffusion of nutrients and
oxygen, leading to lower metabolic activity in the cells
[18, 26, 28, 33, 34]. Thus, differences in biofilmmatrix
structure can explain the differences in metabolic
activity between all time points assayed of biofilms
and between C. tropicalis strains.
Concerning real-time PCR analysis (Table 1), the
SAPT genes were expressed during C. tropicalis
biofilm formation in the presence of AU. It has been
widely reported that, during the adhesion and invasion
processes of host tissues, Candida species are able to
secrete hydrolytic enzymes that cause damage on host
cells membrane integrity, leading to dysfunction or
disruption of host structures [27, 35, 36]. Additionally,
the expression of SAPT genes by planktonic C.
tropicalis (SAPT1 to SAPT4) has also been demon-
strated on the surface of fungal elements penetrating
cells and tissues during disseminated infection and
evading macrophages after yeast cells phagocytosis
[27, 35, 37]. Although little is known about the
contribution of SAPT genes to Candida biofilm
formation, recent findings [7] showed the ability to
express SAPT genes of C. tropicalis biofilms in AU, in
the presence of human urinary bladder cells (TCC-
SUP). Furthermore, research with C. albicans showed
that this species adhered to abiotic surfaces or in
biofilms producing more secreted SAPs than the
planktonic cells [25, 38].
The SAPT gene expression by C. tropicalis grown
in AU (in planktonic and biofilm forms) showed, in
general, a higher level for SAPT3 expression followed
by lower levels of SAPT2, SAPT1 and SAPT4. Only
two strains (U69 and ATCC 750 strains) in 48-h
biofilms were able to express SAPT1, but in planktonic
form, this gene expression was not detected. These
features were similar to those described by Silva et al.
[27] when studying the expression profiles of SAPT
genes by seven C. tropicalis strains in contact with
reconstituted human oral epithelium.
Nailis et al. [39] found differences in C. albicans
SAP gene expression between in vitro grown biofilms
and in vivo model. In the present study, there is also a
different gene expression among the different modes
of growth. Curiously, SAPT4 was only detected in
ATCC 750 biofilms and at specific biofilm ages.
Furthermore, the levels of SAPT3 expression were
more pronounced in planktonic cells than in biofilm
cells. Other studies indicate that there is an optimum
pH for C. tropicalis-secreted aspartic proteinases
activity, thereby making SAP gene expression strain
and substrate dependent [27, 35, 37]. Additionally, it is
known that cells grown in biofilm form show
222 Mycopathologia (2016) 181:217–224
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differences in metabolic activity when compared to
those grown in planktonic mode. Maybe, this fact can
be an explanation for the difference in SAPT3
expression levels between planktonic and biofilm
cells [7, 33]. This idea is enhanced when it was
observed in previous research [7] with different ages
(24 and 120 h) ofC. tropicalis biofilms and their effect
in human urinary bladder cells where there was a
different gene expression among the different modes
of growth. Also, there are only few studies reportingC.
tropicalis SAP gene expression during the adhesion to
human cells, and there is also limited knowledge about
the role of these enzymes in C. tropicalis biofilms [7,
24, 33].
Conclusions
The present study showed that C. tropicalis strains
assayed were able to form biofilms in silicone and in
the presence of AU although in a strain- and time-
dependent way, and SAPT genes are expressed during
C. tropicalis biofilm formation. Nevertheless, SAPT3
transcript presented the highest level of gene expres-
sion, regardless of biofilm age. However, more studies
have to be performed to clarify whether these SAP
genes are associated with biofilm development and C.
tropicalis virulence potential.
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